ARL67156 trisodium hydrate

ARL67156 trisodium hydrate is a selective ecto-ATPase inhibitor, competitively targeting NTPDase1, NTPDase3, and NPP1 with Ki values of 11, 18, and 12 μM, respectively. It is a valuable research tool for studying purinergic signaling in disease models such as calcific aortic valve disease and asthma, with applications in both in vitro and in vivo experimental systems.